Other important molecules, such as prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA), are also used as significant biomarkers for prostate and colon cancer, respectively, in the biomedical field [7,8]. This evidence concerns the gene CEACAM5 and colonic neoplasm.